NCT02935036View on ClinicalTrials.gov

Efficacy Study in Patients With Acne Vulgaris.

PHASE2CompletedINTERVENTIONAL
Enrollment

294

Participants

Timeline

Start Date

October 3, 2016

Primary Completion Date

January 24, 2017

Study Completion Date

March 21, 2017

Conditions
Acne Vulgaris
Interventions
DRUG

ADPS topical product

topical product

DRUG

Placebo Control

topical product

All Listed Sponsors
lead

Sun Pharmaceutical Industries, Inc.

INDUSTRY

NCT02935036 - Efficacy Study in Patients With Acne Vulgaris. | Biotech Hunter | Biotech Hunter